Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIO NOR AS
AS
Active
Org 947882708
Skøelv, 9310 Sørreisa
Manufacture of homogenised food preparations and dietetic food · NACE 1086
Est. 1988
0 employees
www.bio-nor.no
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2022
NOK 0
EBITDA margin
—
-544% vs 2021
Equity ratio
64.6%
Financial strength
Net profit 2022
NOK -63K
-1312% vs 2021
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
Key figures
Annual report 2022
Revenue
NOK 0
—
EBITDA
NOK -63K
-544%
Net profit
NOK -63K
-1312%
Total assets
NOK 57K
-48%
Equity
NOK 37K
-63%
Employees
0
—
Company information
Legal name
BIO NOR AS
Org number
947882708
Legal form
Aksjeselskap
NACE code
1086 · Manufacture of homogenised food preparations and dietetic food
Founded
1. juli 1988
Share capital
—
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Contact
Address
Skøelv, 9310 Sørreisa
Website
www.bio-nor.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of homogenised food preparations and dietetic food
Companies in Sørreisa
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
Income statement
NOK thousands
Item
2018
2019
2020
2021
2022
Revenue
0
0
0
0
0
Staff expenses
−0
−0
−0
−0
0
EBITDA
1
0
−2
−10
−63
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
1
0
−2
−10
−63
Net financials
0
0
0
0
−0
Profit before tax
1
0
−2
−10
−63
Tax
−0
−0
−0
−5
−0
Net profit
1
0
−2
−4
−63
Balance sheet
NOK thousands
Item
2018
2019
2020
2021
2022
Total assets
88
88
86
109
57
Equity
88
88
86
100
37
Long-term debt
0
0
0
0
0
Short-term debt
0
0
0
9
20
Total debt
0
0
0
9
20
Financial ratios
5-year trend
EBITDA margin
-6334800.0%
This company
15.8%
Market median
-40093771% vs market
2018
2022
Equity ratio
64.6%
This company
38.2%
Market median
+69% vs market
2018
2022
Return on equity
-173.1%
This company
18.4%
Market median
-1041% vs market
2018
2022
Net profit margin
-6343800.0%
This company
8.1%
Market median
-78318619% vs market
2018
2022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2018
2022
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TM
Trond Magne Solstrand
Chief Executive Officer
Chief Executive Officer
2020
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Bioform As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Ovesen Holding As
Bioform As
BIO NOR AS
(this company)
Board network connections
Board members of BIO NOR AS also hold positions in
0
other companies.
Person
Role here
Other companies
Trond Magne Solstrand
Chief Executive Officer
0 companies